Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.
Phair
P G
PG
Department of Nephrology, Royal Children's Hospital, Parkville, Victoria, Australia.
Powell
H R
HR
McCredie
D A
DA
D000293:Adolescent; D000328:Adult; D016718:Arachidonic Acid / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects* / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006463:Hemolytic-Uremic Syndrome / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000139:chemically induced; D010743:Phospholipids / Q000097:blood*; D012016:Reference Values
D005230:Fatty Acids, Nonesterified; D010743:Phospholipids; D016718:Arachidonic Acid; D016572:Cyclosporine; D003404:Creatinine